Crucitta, E: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs

Fogli, Stefano, Porta, Camillo, Del Re, Marzia, Crucitta, Stefania, Gianfilippo, Giulia, Danesi, Romano, Rini, Brian I., Schmidinger, Manuela

Journal:

Cancer Treatment Reviews

Year:

2020

Language:

english

File:

PDF, 1007 KB

english, 2020

2

Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients

Catalano, G, Comella, P, Casaretti, R, Crucitta, E, De Vita, F, Palmeri, S, Avallone, A, Orditura, M, De Lucia, L, Del Prete, S

Journal:

British Journal of Cancer

Year:

2002

Language:

english

File:

PDF, 86 KB

english, 2002

3

Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer

Cappuzzo, F, Novello, S, De Marinis, F, Franciosi, V, Maur, M, Ceribelli, A, Lorusso, V, Barbieri, F, Castaldini, L, Crucitta, E

Journal:

British Journal of Cancer

Year:

2005

Language:

english

File:

PDF, 117 KB

english, 2005

4

Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study

M. De Lena, V. Lorusso, A. Latorre, G. Fanizza, G. Gargano, L. Caporusso, M. Guida, A. Catino, E. Crucitta, D. Sambiasi, A. Mazzei

Journal:

European Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 99 KB

english, 2001

5

Taxol-gemcitabine-vinorelbine (TGV) given every 2 weeks in chemo-naive advanced NSCLC. A SICOG phase I study

G. Frasci, G. De Cataldis, V. Lorusso, P. Comella, L. Maiorino, E. Crucitta, G.P. Nicolella, N. Panza, M. De Lena, G. Comella

Journal:

European Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 187 KB

english, 2001

6

Taxol, gemcitabine and vinorelbine, a very active platinum free triplet in naive patients with Non Small Cell Lung Cancer

E. Crucitta, V. Lorusso, S. Mancarella, N. Panza, A. Catino, M. Guida, A. Latorre, G. Frasci, L. Caporusso, M. De Lena

Journal:

European Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 182 KB

english, 2001

7

O-143 Gemcitabine-oxaliplatin (GEMOX) chemotherapy as first-line treatment in advanced non-small cell lung cancer (NSCLC): Preliminary results of a multicenter phase II study

Crino, Lucio, Novello, Silvia, De Marinis, Filippo, Maur, Michela, Scagliotti, Giorgio, Salvagni, S., Crucitta, E., Maestri, Antonio, Bartolini, Stefania, Cappuzzo, Federico

Journal:

Year:

2003

Language:

english

File:

PDF, 183 KB

english, 2003

8

P-488 Phase II randomized trial of single-agent pemetrexed orsequentially administered pemetrexed/gemcitabine as front-line chemotherapy for the treatment of advanced non-small cell lung cancer (NSCLC) in elderly patients or patients ineligible for platinum-based chemotherapy

Gridelli, C., Reck, M., Gregorc, V., Migliorino, M., Muller, T., Manegold, C., Favaretto, A., Schmittel, A., Caffo, O., Blatter, J., Munoz, M., Crucitta, E., Rossi, A., Koschel, G.

Journal:

Year:

2005

Language:

english

File:

PDF, 140 KB

english, 2005

9

793 Multicenter phase II study of gemcitabine-oxaliplatin (GEMOX) chemotherapy in untreated locally advanced or metastatic non-small cell lung cancer (NSCLC) patients

F. Cappuzzo, S. Novello, F. De Marinis, M. Maur, G. Scagliotti, S. Salvagni, E. Crucitta, S. Bartolini, A. Maestri, L. Crino

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 165 KB

english, 2003

10

A Phase I Study of Capecitabine in Combination with Vinorelbine in Advanced Breast Cancer

Vito Lorusso, Enrico Crucitta, Nicola Silvestris, Michele Guida, Andrea Misino, Agnese Latorre, Mario De Lena

Journal:

Clinical Breast Cancer

Year:

2003

Language:

english

File:

PDF, 96 KB

english, 2003

11

Biweekly irinotecan (IRI) with 6s-folinic acid (FA)-modulated 5-fluorouracil (FU) i.v. bolus in advanced colorectal carcinoma (ACC): a phase III study

Comella, P., De Vita, F., De Lucia, L., Crucitta, E., Biglietto, M., Farris, A., Del Gaizo, F., Palmeri, S., Iannelli, A., Mancarella, S.

Journal:

European Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 160 KB

english, 2001

12

Oxaliplatin (L-OHP) and irinotecan (CPT-11) with 6s-leucovorin (IFA)-modulated 5-fluorouracil (FU) i.v. bolus every 2 weeks: a dose-finding study in patients (pts) with gastrointestinal malignancies

Comella, P., De Vita, F., De Lucia, L., Crucitta, E., Palmeri, S., Casaretti, R., Orditura, M., Avallone, A., Catalano, G., De Lena, M.

Journal:

European Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 160 KB

english, 2001

13

Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer

Lorusso, V, Crucitta, E, Silvestris, N, Catino, A, Caporusso, L, Mazzei, A, Guida, M, Latorre, A, Sambiasi, D, D'Amico, C, Schittulli, F, Calabrese, P, De Lena, M

Journal:

British Journal of Cancer

Year:

2003

Language:

english

File:

PDF, 94 KB

english, 2003

14

Pharmacokinetic Study of Intravesical Gemcitabine in Carcinoma in situ of the Bladder Refractory to Bacillus Calmette-Guérin Therapy

Bassi, P., De Marco, V., Tavolini, I.M., Longo, F., Pinto, F., Zucchetti, M., Crucitta, E., Marini, L., dal Moro, F.

Journal:

Urologia Internationalis

Year:

2005

Language:

english

File:

PDF, 78 KB

english, 2005

15

Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group

Comella, P., Crucitta, E., De Vita, F., De Lucia, L., Farris, A., Del Gaizo, F., Palmeri, S., Iannelli, A., Mancarella, S., Tafuto, S., Maiorino, L., Buzzi, F., De Cataldis, G.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 95 KB

english, 2002

16

Current status and future potential role of exemestane in the treatment of early and advanced breast cancer (Review)

Crucitta, E., Fornier, M., Locopo, N., Silvestris, N., Lorusso, V., De Lena, M.

Journal:

International Journal of Oncology

Year:

2002

Language:

english

File:

PDF, 1.62 MB

english, 2002

17

Epithelial ovarian cancer: Second and third line chemotherapy (Review)

Latorre, A., De Lena, M., Catino, A., Crucitta, E., Sambiasi, D., Guida, M., Misino, A., Lorusso, V.

Journal:

International Journal of Oncology

Year:

2002

Language:

english

File:

PDF, 2.35 MB

english, 2002

18

New aromatase inhibitors in the treatment of advanced breast cancer.

Crucitta, E, Lorusso, V, Attolico, M, Sambiasi, D, Mazzei, A, De Lena, M

Journal:

International Journal of Oncology

Year:

2000

Language:

english

File:

PDF, 1.55 MB

english, 2000

19

AIDS-related non-Hodgkin's lymphoma: Clinico-pathological characteristics and therapeutic strategies (Review)

Silvestris, N., Crucitta, E., Lorusso, V., Gamucci, T., De Lena, M.

Journal:

International Journal of Oncology

Year:

2002

Language:

english

File:

PDF, 1.53 MB

english, 2002

20

Rationale for the use of gemcitabine in breast cancer (Review)

Silvestris, N., D'Aprile, M., Andreola, G., Locopo, N., Marini, L., Crucitta, E., De Lena, M., Lorusso, V.

Journal:

International Journal of Oncology

Year:

2004

Language:

english

File:

PDF, 2.72 MB

english, 2004

21

Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel?

Del Re, M., Citi, V., Crucitta, S., Rofi, E., Belcari, F., van Schaik, R.H., Danesi, R.

Journal:

Pharmacological Research

Year:

2016

Language:

english

File:

PDF, 740 KB

english, 2016

22

Metastatic malignant melanoma of the gallbladder

Guida, M, Cramarossa, A, Gentile, A, Benvestito, S, De Fazio, M, Sanbiasi, D, Crucitta, E, De Lena, M

Journal:

Melanoma Research

Year:

2002

Language:

english

File:

PDF, 388 KB

english, 2002

23

Apc- driven colon carcinogenesis in pirc rat is strongly reduced by polyethylene glycol

Femia, Angelo Pietro, Becherucci, Caterina, Crucitta, Stefania, Caderni, Giovanna

Journal:

International Journal of Cancer

Year:

2015

Language:

english

File:

PDF, 183 KB

english, 2015

24

The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients

Del Re, Marzia, Biasco, Elisa, Crucitta, Stefania, Derosa, Lisa, Rofi, Eleonora, Orlandini, Cinzia, Miccoli, Mario, Galli, Luca, Falcone, Alfredo, Jenster, Guido W., van Schaik, Ron H., Danesi, Romano

Journal:

European Urology

Year:

2016

Language:

english

File:

PDF, 834 KB

english, 2016

25

The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide

Del Re, Marzia, Fogli, Stefano, Derosa, Lisa, Massari, Francesco, De Souza, Paul, Crucitta, Stefania, Bracarda, Sergio, Santini, Daniele, Danesi, Romano

Journal:

Cancer Treatment Reviews

Year:

2017

Language:

english

File:

PDF, 860 KB

english, 2017

26

Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi's Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680–7

Del Re, Marzia, Biasco, Elisa, Crucitta, Stefania, Derosa, Lisa, Rofi, Eleonora, Orlandini, Cinzia, Miccoli, Mario, Galli, Luca, Falcone, Alfredo, Jenster, Guido W., van Schaik, Ron H., Danesi, Romano

Journal:

European Urology

Year:

2017

Language:

english

File:

PDF, 126 KB

english, 2017

27

AR-V7 detection in plasma-derived exosomal RNA strongly predicts resistance to hormonal therapy in metastatic prostate cancer

Del Re, M., Biasco, E., Crucitta, S., Derosa, L., Rofi, E., Farnesi, A., Sbrana, A., Restante, G., Galli, L., Falcone, A., Jenster, G., van Schaik, R.H.N., Danesi, R.

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 34 KB

english, 2016

28

Pharmacogenetics and Metabolism from Science to Implementation in Clinical Practice: The Example of Dihydropyrimidine Dehydrogenase

Re, Marzia Del, Restante, Giuliana, Di Paolo, Antonello, Crucitta, Stefania, Rofi, Eleonora, Danesi, Romano

Journal:

Current Pharmaceutical Design

Year:

2017

Language:

english

File:

PDF, 1.52 MB

english, 2017

29

Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells

Del Re, Marzia, Arrigoni, Elena, Restante, Giuliana, Passaro, Antonio, Rofi, Eleonora, Crucitta, Stefania, De Marinis, Filippo, Di Paolo, Antonello, Danesi, Romano

Journal:

Year:

2018

Language:

english

File:

PDF, 254 KB

english, 2018

30

D13Analysis of DPYD and UGT1A1 genotype in patients with advanced pancreatic cancer treated with modified FOLFIRINOX

Vivaldi, C, Arrigoni, E, Morganti, R, Pecora, I, Fidilio, L, Catanese, S, Restante, G, Fornaro, L, Crucitta, S, Lencioni, M, Rofi, E, Vasile, E, Falcone, A, Danesi, R, Del Re, M

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 49 KB

english, 2017

31

Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment

Arrigoni, Elena, Del Re, Marzia, Galimberti, Sara, Restante, Giuliana, Rofi, Eleonora, Crucitta, Stefania, Baratè, Claudia, Petrini, Mario, Danesi, Romano, Di Paolo, Antonello

Journal:

Stem Cells Translational Medicine

Year:

2018

Language:

english

File:

PDF, 492 KB

english, 2018

32

1691PAnalysis of DPYD and UGT1A1 genotype in patients with advanced pancreatic cancer treated with modified FOLFIRINOX

Vivaldi, C., Arrigoni, E., Morganti, R., Catanese, S., Fidilio, L., Pecora, I., Restante, G., Fornaro, L., Crucitta, S., Lencioni, M., Rofi, E., Vasile, E., Falcone, A., Danesi, R., Del Re, M.

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 69 KB

english, 2017

33

PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC

Del Re, Marzia, Marconcini, Riccardo, Pasquini, Giulia, Rofi, Eleonora, Vivaldi, Caterina, Bloise, Francesco, Restante, Giuliana, Arrigoni, Elena, Caparello, Chiara, Bianco, Maria Grazia, Crucitta, St

Journal:

British Journal of Cancer

Year:

2018

Language:

english

File:

PDF, 601 KB

english, 2018

34

Pharmacogenetics of androgen signaling in prostate cancer: focus on castration resistance and predictive biomarkers of response to treatment

Del Re, Marzia, Crucitta, Stefania, Restante, Giuliana, Rofi, Eleonora, Arrigoni, Elena, Biasco, Elisa, Sbrana, Andrea, Coppi, Erika, Galli, Luca, Bracarda, Sergio, Santini, Daniele, Danesi, Romano

Journal:

Critical Reviews in Oncology/Hematology

Year:

2018

Language:

english

File:

PDF, 979 KB

english, 2018

35

EGFR-TKIs in non-small-cell lung cancer: focus on clinical pharmacology and mechanisms of resistance

Fogli, Stefano, Polini, Beatrice, Re, Marzia Del, Petrini, Iacopo, Passaro, Antonio, Crucitta, Stefania, Rofi, Eleonora, Danesi, Romano

Journal:

Pharmacogenomics

Year:

2018

Language:

english

File:

PDF, 2.19 MB

english, 2018

36

Gene Expression Profile of Colon Mucosa after Cytotoxic Insult in wt and Apc -Mutated Pirc Rats: Possible Relation to Resistance to Apoptosis during Carcinogenesis

Femia, Angelo Pietro, Luceri, Cristina, Lodovici, Maura, Crucitta, Stefania, Caderni, Giovanna

Journal:

BioMed Research International

Year:

2016

Language:

english

File:

PDF, 1.80 MB

english, 2016

37

C01*The detection of AR-V7 in plasma-derived exosomal RNA strongly predicts resistance to hormonal therapy in metastatic prostate cancer patients

Del Re, M., Biasco, E., Crucitta, S., Derosa, L., Rofi, E., Sbrana, A., Farnesi, A., Restante, G., Galli, L., Falcone, A., Jenster, G., van Schaik, R., Danesi, R.

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 33 KB

english, 2016

38

Amifostine as chemoprotectant in metastatic breast cancer patients treated with doxorubicin

Catino, Annamaria, Crucitta, Enrico, Latorre, Agnese, Sambiasi, Domenico, Calabrese, Pietro, Lorusso, Vito

Journal:

Oncology Reports

Year:

2003

Language:

english

File:

PDF, 1.27 MB

english, 2003

39

169PSelective induction of PD-L1 expression in plasma-derived exosomes by gemcitabine-nab-paclitaxel vs. FOLFIRINOX in pancreas cancer

Rofi, E, Del Re, M, Vivaldi, C, Crucitta, S, Arrigoni, E, Pasquini, G, Catanese, S, Pecora, I, Musettini, G, Vasile, E, Falcone, A, Danesi, R

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 79 KB

english, 2018

40

The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response

Del Re, Marzia, Bordi, Paola, Rofi, Eleonora, Restante, Giuliana, Valleggi, Simona, Minari, Roberta, Crucitta, Stefania, Arrigoni, Elena, Chella, Antonio, Morganti, Riccardo, Tiseo, Marcello, Petrini,

Journal:

British Journal of Cancer

Year:

2018

Language:

english

File:

PDF, 748 KB

english, 2018

41

145PExpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical response to CDK4/6 inhibitors in breast cancer

Crucitta, S, Del Re, M, Fontana, A, Bertolini, I, Rofi, E, De Angelis, C, Diodati, L, Cavallero, D, Salvadori, B, Falcone, A, Morganti, R, Danesi, R

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 74 KB

english, 2018

42

The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer

Rofi, Eleonora, Vivaldi, Caterina, Del Re, Marzia, Arrigoni, Elena, Crucitta, Stefania, Funel, Niccola, Fogli, Stefano, Vasile, Enrico, Musettini, Gianna, Fornaro, Lorenzo, Falcone, Alfredo, Danesi, R

Journal:

Pharmacogenomics

Year:

2018

Language:

english

File:

PDF, 1.31 MB

english, 2018

43

The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report

Del Re, Marzia, Rofi, Eleonora, Cappelli, Carla, Puppo, Gianfranco, Crucitta, Stefania, Valeggi, Simona, Chella, Antonio, Danesi, Romano, Petrini, Iacopo

Journal:

Year:

2019

Language:

english

File:

PDF, 563 KB

english, 2019

44

Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients

Del Re, Marzia, Bertolini, Ilaria, Crucitta, Stefania, Fontanelli, Lorenzo, Rofi, Eleonora, De Angelis, Claudia, Diodati, Lucrezia, Cavallero, Diletta, Gianfilippo, Giulia, Salvadori, Barbara, Fogli,

Journal:

Breast Cancer Research and Treatment

Year:

2019

Language:

english

File:

PDF, 594 KB

english, 2019

45

Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy

Del Re, Marzia, Crucitta, Stefania, Gianfilippo, Giulia, Passaro, Antonio, Petrini, Iacopo, Restante, Giuliana, Michelucci, Angela, Fogli, Stefano, de Marinis, Filippo, Porta, Camillo, Chella, Antonio

Journal:

International Journal of Molecular Sciences

Year:

2019

Language:

english

File:

PDF, 933 KB

english, 2019

46

Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients

Del Re, Marzia, Bertolini, Ilaria, Crucitta, Stefania, Fontanelli, Lorenzo, Rofi, Eleonora, De Angelis, Claudia, Diodati, Lucrezia, Cavallero, Diletta, Gianfilippo, Giulia, Salvadori, Barbara, Fogli,

Journal:

Breast Cancer Research and Treatment

Year:

2019

File:

PDF, 594 KB

2019

47

Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring

Pasqualetti, Francesco, Restante, Giuliana, Gonnelli, Alessandra, Rofi, Eleonora, Molinari, Alessandro, Crucitta, Stefania, Paiar, Fabiola, Rudà, Roberta, Danesi, Romano, Soffietti, Riccardo, Del Re,

Journal:

Year:

2019

Language:

english

File:

PDF, 511 KB

english, 2019

48

Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy

Crucitta, Stefania, Restante, Giuliana, Del Re, Marzia, Bertolini, Ilaria, Bona, Eleonora, Rofi, Eleonora, Fontanelli, Lorenzo, Gianfilippo, Giulia, Fogli, Stefano, Stasi, Irene, Ghilli, Matteo, Fonta

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2019

Language:

english

File:

PDF, 840 KB

english, 2019

49

Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring

Pasqualetti, Francesco, Restante, Giuliana, Gonnelli, Alessandra, Rofi, Eleonora, Molinari, Alessandro, Crucitta, Stefania, Paiar, Fabiola, Rudà, Roberta, Danesi, Romano, Soffietti, Riccardo, Del Re,

Journal:

Year:

2019

File:

PDF, 511 KB

2019

50

1561PIncidence of T790M in NSCLC patients progressed to gefitinib, erlotinib, and afatinib: A study on circulating tumour DNA

Danesi, R, Petrini, I, Mazzoni, F, Valleggi, S, Gianfilippo, G, Pozzessere, D, Crucitta, S, Restante, G, Chella, A, Garassino, M C, Miccoli, M, Re, M Del

Journal:

Annals of Oncology

Year:

2019

Language:

english

File:

PDF, 77 KB

english, 2019